Tallgrass Energy GP LP TEGP 深 沪
等待开盘 12-03 09:30:00 美东时间
22.13
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 22.13
- 总市值 34.79亿
- 52周最高 28.94
- 市盈率 静 20.61
- 换手率 0.00%
- 52周最低 17.14
- 委 比 0.00%
- 总股本 1.57亿
- 历史最高 34.98
- 量 比 0
- 振 幅 0.00%
- 历史最低 9.66
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Longeveron® to Report Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025
Longeveron Inc. will announce its third quarter 2025 financial results and provide a business update on November 4, 2025. The company will hold a conference call and webcast at 4:30 p.m. ET on the same day. Details for the call and webcast are available on the company's website. Longeveron focuses on developing regenerative medicines to treat life-threatening and rare conditions, with its lead product laromestrocel targeting areas like hypoplasti...
10-28 13:15
George Paletta, Jr., MD, MBA, Internationally Acclaimed Entrepreneur, Investor and Surgeon, Elected to Longeveron® Board of Directors
Longeveron Inc. announced the election of George Paletta, Jr., MD, MBA, to its Board of Directors. Dr. Paletta, a nationally recognized orthopedic surgeon and entrepreneur, brings extensive experience in healthcare and business to the company. His expertise is expected to support Longeveron's stem cell therapy advancements targeting life-threatening conditions in children and the elderly. Longeveron is currently advancing multiple pipeline indica...
10-01 20:05
TEGNA Names Brent Denny President and General Manager at WTHR in Indianapolis
Brent Denny has been appointed President and General Manager of TEGNA’s WTHR and WALV in Indianapolis, effective immediately. With over 30 years in broadcasting, Denny will oversee station operations, financial performance, and community service. Previously, he served as director of sales, driving revenue growth. Larry Delia praised Denny’s leadership and community impact. Denny expressed enthusiasm for upholding WTHR/WALV’s legacy and serving In...
08-21 18:00
Longeveron Announces Up To $17.5 Million Public Offering
Longeveron Inc. has priced a public offering of 5.88 million Class A common shares and short-term warrants to raise up to $5 million upfront and $12.5 million from warrants. The short-term warrants are exercisable at $0.85 per share over 24 months. Proceeds will fund clinical development, regulatory approvals, capital expenditures, and general corporate purposes. H.C. Wainwright & Co. is the exclusive placement agent.
08-08 17:28
Longeveron® to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
<p>MIAMI, June 09, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines for aging-related conditions, announced that CEO Wa’el Hashad will present at the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference on June 16-17, 2025. A pre-recorded presentation will be available on June 16 at 7:00 a.m. ET via the provided webcast link. Longeveron is focused on devel...
06-09 13:15
